I. [Product Description]
This compound is an important organic intermediate. Its core characteristic lies in the combination of FITC labeling with poly(lactic-co-glycolic acid) (PLGA) nanoparticles, and it is loaded with doxorubicin/Prussian blue. It has unique physical and chemical properties and is of great value in the field of relevant chemical synthesis.

II. [Product Details]
【Appearance】Depending on different molecular weights, it appears as a white/off-white solid or a viscous liquid.
【Stability】Store in a refrigerator and avoid repeated freezing and thawing.
【Solvent】Common organic solvents such as chloroform and DMSO.
【Molecular Weight】2K, 5K, 10K, 20K, 50K, 100K, etc. Other molecular weights can be customized.
【Storage Conditions】Store in a sealed and dry place at a low temperature below 4°C.
▪ Notes: ▶ To ensure product stability, please open the package for use only after constant temperature drying!

III. [Application Fields]
1. For the preparation and research of nanomaterials.
2. Applied in experiments related to fluorescence labeling.
3. Used in the surface modification of materials.
4. Can be used to construct composite functional materials.
5. Participate in specific chemical synthesis reactions.

Remarks: The products sold by our company are only for scientific research and cannot be used for human experiments or human treatment.

Chongqing Yusi Pharmaceutical Technology Co., Ltd. operates based on an integrated business model of independent R & D-production-sales, providing professional scientific research reagents for university scientific research experiments. Compared with similar products on the market, our company's products have obvious price advantages. In addition, we also provide professional product customization services.

If you need other products, please contact us:
Contact Information:
Landline: 023-62795528
Customer Service Hotline: 19923757617 丨 QQ: 3279537175
                                           19112925095 丨 QQ: 3012135199

Similar Product Recommendations:
1. FITC-labeled poly(lactic acid) nanoparticles
2. PLGA-loaded doxorubicin nanoparticles
3. Prussian blue nanoparticles
4. FITC-labeled liposomes
5. PLGA-PEG nanoparticles
6. Doxorubicin-loaded liposomes
7. FITC-PB nanocomposites
8. Poly(lactic-co-glycolic acid) microspheres
9. Modified FITC-labeled nanomaterials
10. Prussian blue-loaded PLGA nanoparticles
11. Doxorubicin-modified nanocarriers
12. Fluorescently-labeled PLGA materials